Annual Financial Statements

celebrating 20 years Group statement of cash flows

for the year ended 30 June 2018

 

  Notes 2018
R’million
2017
R’million
Cash flows from operating activities      
Cash generated from operations A 10 328 9 902
Financing costs paid B (2 077) (2 200)
Investment income received C 261 287
Tax paid D (1 495) (1 502)
Cash generated from operating activities   7 017 6 487
Cash flows from investing activities      
Capital expenditure – property, plant and equipment   (2 145) (1 484)
Proceeds on the sale of property, plant and equipment   17 9
Capital expenditure – intangible assets   (881) (1 147)
Acquisition of residual rights – AZ Anaesthetics E (5 202)
Proceeds on the sale of intangible assets   62 832
Acquisition of subsidiaries and businesses G (152) (9 428)
Disposal of subsidiary   45
Acquisition of joint venture   (52)
Payment of deferred fixed and contingent consideration relating to prior year business acquisitions   (4 599) (192)
Proceeds received from/(investment in) other non-current assets   50 (291)
Proceeds on the sale of assets classified as held-for-sale   37 91
Cash used in investing activities   (12 813) (11 617)
Cash flows from financing activities      
Proceeds from borrowings   19 186 25 251
Repayment of borrowings   (11 496) (19 032)
Dividends paid   (1 313) (1 230)
Treasury shares purchased   (44) (33)
Cash generated from financing activities   6 333 4 956
Movement in cash and cash equivalents before currency translation movements   537 (174)
Currency translation movements   389 (526)
Movement in cash and cash equivalents   926 (700)
Cash and cash equivalents at the beginning of the year   7 188 7 888
Cash and cash equivalents at the end of the year F 8 114 7 188


For the purposes of the statement of cash flows, cash and cash equivalents comprise bank balances, short-term bank deposits less bank overdrafts.